Figure 9 | Scientific Reports

Figure 9

From: Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents

Figure 9

(A) Flow cytometric quantification of Annexin V-FITC and PI double labelled A549 cells after treatment with cisplatin, 4a and 4b for 24 h at the indicated concentrations. The excitation wavelength was 488 nm and the emission was monitored at 525 ± 20 nm for Annexin V-FITC and 615 ± 20 nm for PI. (B) Activation of caspase 3/7 in A549 cells by Ir(III) treatment. The cells were incubated with cisplatin, 4a and 4b at the indicated concentrations for 24 h. (C) The effects of the pan-caspase inhibitor z-VAD-fmk on Ir(III)-induced cell death. Cells were pre-incubated with z-VAD-fmk for 1 h and then treated with cisplatin, 4a and 4b for 24 h. **p < 0.02.

Back to article page